HAIF is an AI-powered algorithm that analyzes standard 12-lead ECGs to predict heart failure months before symptoms appear. It characterizes the heart’s mechanical function without requiring additional tests, enabling fast, non-invasive screening and early intervention.
* Heart Failure Predictor: Patient's risk of heart failure.
* Blood potassium estimation: Blood potassium levels from ECG, without a needle prick.
* Blood glucose estimation: Blood sugar levels from ECG, without a needle prick.
* Coronary ischaemia screener: Patient's risk of heart attack.
Startup Description
Founded on December 21, 2023, in Delaware and operated from California, we embarked on our mission with a clear vision and a relentless drive to make a difference in cardiology. Our roots trace back to the visionary minds at AmberTAG Inc., our promoter, who saw the potential in harnessing AI to revolutionize heart failure management.
Product Screenshots
Business Model
* We partner directly with healthcare institutions and device manufacturers.
* Licenses are sold in bulk to our partners at a competitive rate of ~$20.00 per Test.
* Partners may purchase large quantities to accommodate their extensive user base.
* Our partners integrate the licenses into their systems and devices.
* They then charge their customers for the additional check test for Heart Failure.
Customers
based in
India, North America
Business
Modal Type
Marketplace
Type of
Sales
B2B, B2C
Competitors
N/A
Teams
Amar Ray
Founder & Chief Executive Officer
Bharat Vijay
Chief Technology Officer
Dr. Abhijit Ray
Chief Clinical Officer
Are all the founders full-time on this
project?
Yes
Looking for an
opportunity to invest in companies
like HAIF Inc?
